The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The ECVAM International Validation Study on in Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test
Abstract
ECVAM sponsored a formal validation study on three in vitro tests for skin irritation, of which two employ reconstituted human epidermis models (EPISKIN™, EpiDerm™), and one, the skin integrity function test (SIFT), employs ex vivo mouse skin. The goal of the study was to assess whether the in vitro tests would correctly predict in vivo classifications according to the EU classification scheme, “R38” and “no label” (i.e. non-irritant). 58 chemicals (25 irritants and 33 non-irritants) were tested, having been selected to give broad coverage of physico–chemical properties, and an adequate distribution of irritancy scores derived from in vivo rabbit skin irritation tests. In Phase 1, 20 of these chemicals (9 irritants and 11 non-irritants) were tested with coded identities by a single lead laboratory for each of the methods, to confirm the suitability of the protocol improvements introduced after a prevalidation phase. When cell viability (evaluated by the MTT reduction test) was used as the endpoint, the predictive ability of both EpiDerm and EPISKIN was considered sufficient to justify their progression to Phase 2, while the predictive ability of the SIFT was judged to be inadequate. Since both the reconstituted skin models provided false predictions around the in vivo classification border (a rabbit Draize test score of 2), the release of a cytokine, inter-leukin-1α (IL-1α), was also determined. In Phase 2, each human skin model was tested in three laboratories, with 58 chemicals. The main endpoint measured for both EpiDerm and EPISKIN was cell viability. In samples from chemicals which gave MTT assay results above the threshold of 50% viability, IL-1α release was also measured, to determine whether the additional endpoint would improve the predictive ability of the tests. For EPISKIN, the sensitivity was 75% and the specificity was 81% (MTT assay only); with the combination of the MTT and IL-1α assays, the sensitivity increased to 91%, with a specificity of 79%. For EpiDerm, the sensitivity was 57% and the specificity was 85% (MTT assay only), while the predictive capacity of EpiDerm was not improved by the measurement of IL-1α release. Following independent peer review, in April 2007 the ECVAM Scientific Advisory Committee endorsed the scientific validity of the EPISKIN test as a replacement for the rabbit skin irritation method, and of the EpiDerm method for identifying skin irritants as part of a tiered testing strategy. This new alternative approach will probably be the first use of in vitro toxicity testing to replace the Draize rabbit skin irritation test in Europe and internationally, since, in the very near future, new EU and OECD Test Guidelines will be proposed for regulatory acceptance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OECD (2005) · OECD Series on Testing and Assessment · doi:10.1787/e1f1244b-en · Cited by 207
Cited by
Skin tissue engineering — In vivo and in vitro applications
Groeber, F., Holeiter, M., Hampel, M., Hinderer, S., & Schenke-Layland, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.005 · Cited by 633
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
Skin-on-a-chip model simulating inflammation, edema and drug-based treatment
Wufuer, M., Lee, G., Hur, W., Jeon, B., Kim, B. J., Choi, T. H., & Lee, S. (2016) · Scientific Reports · doi:10.1038/srep37471 · Cited by 356
Bernard, M., Jubeli, E., Pungente, M. D., & Yagoubi, N. (2018) · Biomaterials Science · doi:10.1039/c8bm00518d · Cited by 350
Wang, W., Wat, E., Hui, P. C. L., Chan, B., Ng, F. S. F., Kan, C.-W., Wang, X., Hu, H., Wong, E. C. W., Lau, C. B. S., et al. (2016) · Scientific Reports · doi:10.1038/srep24112 · Cited by 130
Metadata
- Authors
- Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J. H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I., & Zuang, V.
- Venue
- Alternatives to Laboratory Animals
- Publisher
- SAGE Publications
- Published
- 2007-12
- Volume
- 35
- Issue
- 6
- Pages
- 559-601
- ISSN
- 0261-1929 (ISSN-L)
- 2632-3559
- OpenAlex
- W61220348
- Cited by
- 230
- References
- 1
- FWCI
- 22.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The ECVAM International Validation Study on in Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test. https://app.cochat.ai/papers/10.1177/026119290703500614
- The paper
- Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J. H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., . . . Zuang, V. (2007). The ECVAM International Validation Study on in Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test. Alternatives to Laboratory Animals. https://doi.org/10.1177/026119290703500614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.